Tag: crohn’s

October 17, 2016

Takeda's Vedolizumab Demonstrated Robust Clinical Effectiveness and Safety in Inflammatory Bowel Disease in More Than 50 Real-World Studies

Takeda Pharmaceutical is presenting data on the real-world effectiveness and safety of vedolizumab in patients with moderately to severely active...
October 15, 2016

Pfizer to Present New Data on XELJANZ® for Ulcerative Colitis at UEG Week 2016

Pfizer announced that three abstracts for XELJANZ®, being investigated in moderate to severe ulcerative colitis (UC), will be presented at...
October 3, 2016

Allergan Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to Inflammatory Disorder Development Program

Under the terms of the agreement, Allergan will make an upfront payment to AstraZeneca of $250 million for the exclusive,...